Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

619
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
619
Vaccinations01:51

Vaccinations

48.9K
Overview
48.9K
Development of Immunocompetence01:22

Development of Immunocompetence

565
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
565
Cross-reactivity00:42

Cross-reactivity

32.0K
Overview
32.0K
Cancer Vaccines01:30

Cancer Vaccines

605
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
605
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

291
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
291

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influenza Vaccine Technology Transfer: A Mixed-Methods Study with Vaccine Manufacturers and Global Experts to Assess Successes, Challenges, and Opportunities.

Vaccines·2026
Same author

Global vaccine development.

Nature medicine·2026
Same author

Leaving WHO does not serve America's-or the world's-best interests.

Science (New York, N.Y.)·2026
Same author

Magical thinking will not prevent future pandemics or improve public health.

Science (New York, N.Y.)·2026
Same author

Sustaining Local Production of Influenza Vaccines: A Global Study of Enabling Factors Among Vaccine Manufacturers.

Vaccines·2025
Same author

Estimating the economic burden of invasive non-typhoidal <i>Salmonella</i> infections in low- and middle-income countries.

BMJ global health·2025

Related Experiment Video

Updated: Nov 9, 2025

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.3K

Vaccine development for emerging infectious diseases.

Jean-Louis Excler1, Melanie Saville2, Seth Berkley3

  • 1International Vaccine Institute, Seoul, Republic of Korea. Jeanlouis.excler@ivi.int.

Nature Medicine
|April 13, 2021
PubMed
Summary

Lessons from past pandemics inform COVID-19 vaccine strategies. Addressing challenges in rapid development, manufacturing, safety, and equitable distribution is crucial for controlling current and future infectious disease outbreaks.

More Related Videos

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.8K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.6K

Related Experiment Videos

Last Updated: Nov 9, 2025

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.3K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.8K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.6K

Area of Science:

  • Vaccinology
  • Infectious Diseases
  • Public Health

Background:

  • Emerging and reemerging infectious diseases, including COVID-19, present significant global health challenges.
  • Past pandemics offer valuable insights into vaccine development and deployment strategies.

Purpose of the Study:

  • To examine COVID-19 vaccine strategies and platforms in light of historical pandemic responses.
  • To identify mutually beneficial lessons for current and future pandemic preparedness.

Main Methods:

  • Comparative analysis of vaccine strategies and technical platforms used during the COVID-19 pandemic versus previous infectious disease outbreaks.
  • Review of challenges in rapid vaccine development, manufacturing, distribution, safety surveillance, and variant monitoring.

Main Results:

  • The scale and speed of recent pandemics create unique challenges for all stakeholders.
  • Balancing speed with rigorous clinical development, safety monitoring, and equitable access is essential.
  • Prioritizing vaccine access in low- and middle-income countries is critical for global success.

Conclusions:

  • Integrating lessons from past pandemics can enhance responses to emerging infectious diseases.
  • Successful control of pandemics requires a multifaceted approach encompassing rapid innovation, robust regulation, and equitable global access to vaccines.